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Abstract: Healthcare-associated infections (HAIs) contribute to patient morbidity and mortality with
an estimated 1.7 million infections and 99,000 deaths costing USD $28–34 billion annually in the
United States alone. There is little understanding as to if current environmental surface disinfection
practices reduce pathogen load, and subsequently HAIs, in critical care settings. This evidence map
includes a systematic review on the efficacy of disinfecting environmental surfaces in healthcare
facilities. We screened 17,064 abstracts, 635 full texts, and included 181 articles for data extraction
and study quality assessment. We reviewed ten disinfectant types and compared disinfectants with
respect to study design, outcome organism, and fourteen indictors of study quality. We found
important areas for improvement and gaps in the research related to study design, implementation,
and analysis. Implementation of disinfection, a determinant of disinfection outcomes, was not
measured in most studies and few studies assessed fungi or viruses. Assessing and comparing
disinfection efficacy was impeded by study heterogeneity; however, we catalogued the outcomes
and results for each disinfection type. We concluded that guidelines for disinfectant use are primarily
based on laboratory data rather than a systematic review of in situ disinfection efficacy. It is critically
important for practitioners and researchers to consider system-level efficacy and not just the efficacy
of the disinfectant.
Keywords: disinfection; healthcare facilities; healthcare-associated infections; environmental sur-
faces; infection prevention and control
1. Introduction
Healthcare-associated infections (HAIs) contribute to patient morbidity and mortality
with an estimated 687,000 infections and 72,000 deaths in the United States in 2015 [1]
and an additional 2.6 million annual infections in the European Union [2]. The burden of
HAIs is higher in low- and middle-income countries [3–5]. HAIs are often correlated with
the presence of contaminated environmental surfaces and are exacerbated by multi-drug
resistance and compounded by spore-producing or biofilm-associated pathogens that are
difficult to disinfect [6]. Healthcare-associated pathogens with high morbidity and mortal-
ity, including vancomycin-resistant Enterococci (VRE), methicillin-resistant Staphylococcus
Int. J. Environ. Res. Public Health 2021, 18, 11100. https://doi.org/10.3390/ijerph182111100 https://www.mdpi.com/journal/ijerph
Int. J. Environ. Res. Public Health 2021, 18, 11100 2 of 22
aureus (MRSA), Clostridium difficile, and Candida auris, are especially problematic in the
intensive care unit (ICU), where patients are often immunocompromised [7,8].
The environmental transmission pathways of pathogens and HAIs are varied. They
include medical devices, air ventilation units, environmental surfaces (e.g., floors, bedrails),
water, healthcare workers (e.g., hands), and mobile elements (e.g., wheelchairs, shoes, etc.);
floors may play a large role [9–12]. Meta-analyses support the environment as being a
transmission pathway through roommates/prior occupants with HAIs in high-income
settings [13,14]. Patients hospitalized in rooms previously occupied by people infected
with HAIs are at increased odds of HAI acquisition compared to patients whose prior room
occupant was negative for HAIs [15–17].
Interventions to reduce the environment as a transmission pathway for HAIs are
also varied. Improved cleaning procedures [18,19], training environmental service person-
nel [20–22], hand hygiene [10–12,23], and bundled disinfection interventions reduce the
concentrations of pathogens on environmental surfaces and reduce HAIs in healthcare
facilities [19,24]. However, transmission pathways are poorly disaggregated. For bundled
interventions, it is challenging to determine each component’s independent effect and the
contribution of potential transmission pathways on HAI acquisition. The literature has
focused on multimodal strategies in infection prevention and control (IPC) without analyz-
ing the impact of separate components, such as disinfection implementation or disinfection
efficacy [25]. Understanding the efficacy of the individual components of multi-modal
strategies may help guide bundle development and may aid in decision-making in low-
resource settings.
One systematic review found that most studies that included bundled interventions
with an environmental cleaning and disinfection component were more effective than
bundled interventions without the component at reducing HAIs [26]. Nevertheless, the
extent to which surface disinfection contributes to HAI reductions is unclear.
The hierarchy of studies for assessing the impact of infection control is outcomes
from (1) in vitro reduction of reference pathogens → (2) in situ reduction of environmen-
tal pathogens → (3) colonization and pathogen transmission to patients → (4) patient
HAIs [27,28]. In vitro studies, such as quantitative carrier tests, are appropriate for deter-
mining the disinfectant concentration and contact time necessary to provide a log reduction
target of pathogens on surfaces [29,30]. Large bodies of in vitro surface disinfection re-
search exist for agriculture, food production and preparation, and biodefense but are not
always applicable to pathogens that are regularly associated with HAIs. In vitro studies
on surface disinfection provide the necessary disinfection kinetics to justify in situ studies
yet lack the variance in surfaces, environmentally derived pathogens, and inadequate
terminal cleaning methods. There are reported reductions in disinfection efficacy in the
healthcare facility setting in situ when compared to reported in vitro efficacy (see, e.g., [31]).
Additionally, pathogens remain viable on porous and non-porous surfaces for extended
times in ambient conditions [32–35].
There is still little understanding as to if current disinfection practices on environmen-
tal surfaces reduce pathogen load and subsequently HAIs in critical care settings. There
has not been a rigorous systematic review of the efficacy of disinfection interventions in
situ. While a prior systematic review [28] and related technical brief [36] identified the
disinfection methods used in healthcare facilities on environmental surfaces, the work was
restricted to publications in English and to efficacy on specific Gram-positive pathogens
(MRSA, VRE, C. difficile). The literature primarily concerns multimodal strategies in infec-
tion prevention and control (IPC) without analyzing the impact of separate components [25].
This is exemplified in a systematic review assessing the effect of multi-modal interventions
on HAIs, which reported that 35%–55% of HAIs are preventable but did not differentiate
the multi-faceted components of the interventions [37]. In situ evidence for the efficacy
of disinfection interventions are based on non-systematic methods such as narrative re-
view [38], literature reviews [19], commentary [39], and clinical guidance [40]. Furthermore,
clinical practice guidance for environmental surface cleaning is disparate between evidence-
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based or consensus-driven and narrative-based (i.e., logically justified) recommendations.
Guidelines vary based on country of origin with government, independent associations,
and professional societies issuing 69 separate guidance documents [28].
We conducted a systematic review to develop an evidence map that (1) catalogues
in situ disinfection interventions on environmental surfaces (excepting UV); (2) identifies
gaps in the research and areas for improvement; (3) catalogues the in situ efficacy of
environmental surface disinfection interventions in healthcare facilities on all HAI and
organism outcomes; and (4) summarizes important components of IPC strategies for the
disinfection of environmental surfaces in a proposed framework for ideal disinfection.
2. Materials and Methods
Search Strategy and Machine Learning: We searched PubMed, Embase, Scopus, and
Web of Science in January 2020 for studies related to healthcare facilities and disinfectants
(as described in Supplementary Material 1). Healthcare facility terms included inpatient
and outpatient environments and spanned global healthcare facilities in a variety of critical
care environments. Disinfection terms included specific chemical disinfectants identified
by the Centers for Disease Control and Prevention (CDC) [41] and the World Health Or-
ganization (WHO) [42] for use in health care disinfection, such as alcohols, chlorine and
demand-release chlorine compounds, formaldehyde, glutaraldehyde, hydrogen peroxide,
iodophors, ortho-phthalaldehyde, peracetic acid, phenolics, and quaternary ammonium
compounds as well as non-touch interventions such as vapors and antimicrobial surfaces.
Disinfection terms also included generic terms such as “decontaminant” and “disinfectant”
to identify studies for which we did not specify the disinfectant in the search terms. We
excluded reviews and other article types such as commentaries, as specified in Supporting
Information Supplementary Material 1. After the duplicates were removed, we used ma-
chine learning to prioritize studies to be screened manually for relevance using Document
Classification and Topic Extraction Resource (DoCTER) software (ICF, Fairfax, VA, USA).
All of the studies that were predicted to be relevant by DoCTER were imported to Covi-
dence reference management software (Veritas Health Innovation, Melbourne, Australia)
for title and abstract screening.
We used supervised clustering with an ensemble approach to prioritize studies for
manual screening using the text of titles and abstracts (similar to the approach described
in [43]). Supervised clustering is a form of semi-supervised learning that uses known
relevant studies (i.e., seeds) to identify unclassified studies that are likely to be relevant.
Seed studies are a form of training data but require fewer positive studies than typically
necessary for machine learning algorithms.
To identify seeds, we screened 750 randomly selected studies from which 32 qualifying
studies served as seeds for supervised clustering. One person reviewed studies for use
as seeds, and these studies were confirmed by a subject matter expert. The ensemble
approach uses two algorithms: k-means and non-negative matrix factorization, and three
cluster sizes: 10, 20, and 30. Using each algorithm with the three different cluster numbers
yields six different clustering models (e.g., KM-10 model is the k-means algorithm with
10 clusters, and KM-20 is the k-means algorithm with 20 clusters). The six models were
applied to the title and abstract text. The output of supervised clustering with a six-model
ensemble approach had an ensemble score ranging from 0 to 6 for each study based on the
number of models where the study was found in a relevant cluster (i.e., a cluster with a
high proportion of seed studies). We ran supervised clustering with the 32 seed studies,
and all non-seed studies were given an ensemble score (Figure 1). We specified at least 90
percent recall of relevant studies from the unclassified corpus in DoCTER but a recall closer
to 100 percent was anticipated because all 32 seeds were captured by one or more clusters.
Overall, we expected approximately 95 percent recall by reviewing all of the studies with
an ensemble score of 1 or higher.
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Figure 1. Results of ensemble supervised clustering using 32 seed studies. Studies with an ensemble score of 1 or more 
were screened manually for relevance. 
Inclusion Criteria: Titles and abstracts of all of the studies with an ensemble score of 
1 or higher for relevance, which included the 32 seed studies, were screened. After the 
titles and abstracts were screened, the full text was read to determine if the study would 
be included. Two reviewers independently screened all of the titles and abstracts, and 
disputes were resolved through discussion. One reviewer independently screened the full 
texts for inclusion. The 2061 studies not found to be in a relevant cluster by any model 
(score of 0) were removed from analysis without manual screening (Figure 1). 
Inclusion criteria for title and abstract and full text screening were (1) disinfection 
interventions that did not include UV or other light-based interventions to reduce the 
scope of the systematic review and excluded any study that had a disinfection component 
that was part of a bundled or multi-modal intervention package (e.g., a training interven-
tion was implemented simultaneously to disinfection intervention). Studies were ex-
cluded if the disinfectant was not specified and if the study was cross-sectional in nature 
(e.g., no comparator). (2) We excluded articles that did not sample environmental surfaces, 
which were defined as non-porous surfaces that are either part of the built environment 
(e.g., walls, toilet) of a healthcare facility or remain in the critical care environment during 
the patient’s stay (e.g., bedside table), and did not include studies that focused solely on 
mobile elements such as doctors’ hands, wheelchairs, or medical instruments (e.g., steth-
oscopes, endoscopes). We excluded equipment surfaces, including studies that focused 
solely on central-line and dialysis. We excluded studies that focused on sink traps, the 
inside of showerheads, and porous surfaces (e.g., curtains, linens). If studies included sur-
faces in addition to environmental surfaces in the sampling protocol, we included the 
study. (3) The critical care environment included all healthcare facilities except veterinary, 
long-term residential care, and dental facilities. We excluded areas in healthcare facilities 
that patients would not visit, such as laboratory, laundry, and preparatory areas. We ex-
cluded long-term care facilities because IPC management and implementation may be 
different than other healthcare facilities. (4) Only original, peer-reviewed research was 
included. Systematic reviews, meta-analyses, poster abstracts, and any conference pro-
ceedings were not included. (5) Outcome measurements had to target organisms from 
surfaces, rather than from, e.g., air. We included HAI outcomes. 
Data Extraction and Risk of Bias: Multiple reviewers independently extracted data 
from studies meeting the inclusion criteria. All data were reviewed for quality control by 
one reviewer. Interventions were categorized as being manually applied, antimicrobial 
surfaces applications, or vapors. Disinfectants with multiple active ingredients were cate-
gorized based on the active ingredient with the highest percentage by volume. Antimi-
crobial surfaces were comprised of inherently antibacterial surfaces (e.g., copper) or were 
coated with a product that bonded with the surface to inhibit growth. Coatings that were 
re-applied more than once a week were considered manually applied products rather than 
surface interventions (e.g., [44]). Outcome organisms were grouped into Gram-positive 
Figure 1. Results of ensemble supervised clustering using 32 seed studies. Studies with an ensemble score of 1 or more
were screened manually for relevance.
Inclusion Criteria: Titles and abstracts of all of the studies with an e semble score of 1
or hig er for relevance, whic include the 32 seed studies, wer screen d. After the
ti les and abstracts were scre ned, the full text was read to determine if the study would
be included. Two reviewers independently scre ned all of the ti les and abstracts, and
disputes were resolved through discussion. One reviewer independently screened the full
texts for inclusion. The 2061 studies not found to be in a rel vant cluster by any model
(score of 0) were removed from analysi without manual screeni g (Figure 1).
Inclusion criteria for ti le and abstract and full text scre ning were (1) dis nfection
interventions that di not include UV or other light-based int rventions to reduce the s ope
of the systematic review and exclu d any stud that had a disinfection component that
was part of bundled or multi-modal intervention package (e. ., a training intervention
was implemented simultaneously to disinfection intervention). Studies were excluded if
the disinfectant was not specified and if the study was cross-sectional in nature (e.g., no
comparator). (2) We excluded articles that did not sample environmental surfaces, which
were defined as non-porous surfaces that are either part of the built environment (e.g.,
walls, toilet) of a healthcare facility or remain in the critical care environment during the
patient’s stay (e.g., bedside table), and did not include studies that focused solely on mobile
elements such as doctors’ hands, wheelchairs, or medical instruments (e.g., stethoscopes,
endoscopes). We excluded equipment surfaces, including studies that focused solely on
central-line and dialysis. We excluded studies that focused on sink traps, the inside of
showerheads, and porous surfaces (e.g., curtains, linens). If studies included surfaces
in addition to environmental surfaces in the sampling protocol, we included the study.
(3) The critical care environment included all healthcare facilities except veterinary, long-
term residential care, and dental facilities. We excluded areas in healthcare facilities that
patients would not visit, such as laboratory, laundry, and preparatory areas. We excluded
long-term care facilities because IPC management and implementation may be different
than other healthcare facilities. (4) Only original, peer-reviewed research was included.
Systematic reviews, meta-analyses, poster abstracts, and any conference proceedings were
not included. (5) Outcome measurements had to target organisms from surfaces, rather
than from, e.g., air. We included HAI outcomes.
Data Extraction and Risk of Bias: Multiple reviewers independently extracted data
from studies meeting the inclusion criteria. All data were reviewed for quality control
by one reviewer. Interventions were categorized as being manually applied, antimicro-
bial surfaces applications, or vapors. Disinfectants with multiple active ingredients were
categorized based on the active ingredient with the highest percentage by volume. An-
timicrobial surfaces were comprised of inherently antibacterial surfaces (e.g., copper) or
were coated with a product that bonded with the surface to inhibit growth. Coatings
that were re-applied more than once a week were considered manually applied prod-
ucts rather than surface interventions (e.g., [44]). Outcome organisms were grouped into
Gram-positive cocci, Gram-positive bacilli, Gram-negative bacteria, fungi, viruses, and
Int. J. Environ. Res. Public Health 2021, 18, 11100 5 of 22
“all viable organisms” (non-specific culture media or outcomes that combined multiple
organism types, e.g., multi-drug resistant organisms that combine Gram-negative and
Gram-positive organisms). Outcome measurement quality was ranked in descending
order from organism concentration followed by percent surfaces positive, followed by
adenosine triphosphate (ATP) measurements or qualitative observations; they were then
classified according to highest quality outcome. HAI and antibiotic resistance outcomes
were also identified. Study design was categorized for studies with outcome organisms
(i.e., excluding studies with only HAI outcomes) as crossover design, controlled design
(controlled before-after or controlled cohort study design), or uncontrolled study design
(studies without a contemporary control). All studies were classified according to the
World Bank country income group [45] for study location.
Risk of bias was assessed for each study by two reviewers using a fourteen-point study
quality assessment instrument adapted from the National Institutes of Health (NIH) Study
Quality Assessment Tool [46]. The study quality instrument included fourteen indicators
to assess bias across setting, methods, outcomes, and conclusions of the included studies
with heterogeneous study design; for contemporary controls, baseline equivalence, bias
due to deviation from protocol, blind evaluation, bias due to missing data, bias in selective
reporting, conflicts of interest, and others were considered Supplementary Material 2,
Table S5). Each indicator received a score of 0, 0.5, or 1, such that the maximum total
score for each study was 14. Twenty-three percent of studies were randomly selected for
secondary independent review. Cohen’s kappa statistics and raw percent agreement were
calculated to compare inter-rater reliability for each of the indicators [47].
This review was not registered nor was the review protocol registered. This systematic
review was based on the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) 2020 Checklist [48] (see Supplementary Material 3).
3. Results
The initial literature search identified 17,064 studies, of which 2061 were eliminated
through machine learning (Figure 2). Of the remaining 15,003 articles, 635 articles were
selected for full text review, and were 181 included for data extraction. The included
studies are listed in Supplementary Material 2, Table S6. Characteristics of the included
studies with respect to disinfection intervention type, outcome HAI or organism assessed,
outcome measurement, study design, and World Bank country income group for country
of study location are listed in Table 1.
Manually applied interventions included alcohol, peroxygen, quaternary ammonium
compounds (QACs), sodium hypochlorite, and other chlorine; surface interventions in-
cluded copper and other non-copper surface applications or coatings; and vapor inter-
ventions included hydrogen peroxide interventions. We identified the target pathogens
and/or HAIs measured due to each disinfection intervention and presented an evidence
map and summary of the data relating to study design, organism outcome, and disinfection
intervention.
Most studies (86%) were conducted in high income countries such as the USA, UK,
Italy, and Japan. Studies from upper-middle income countries (10%) were conducted in
Turkey, Brazil, South Africa, Russia, Mexico, Indonesia, China, and Bosnia and Herzegovina.
Studies from lower-middle income countries (3%) comprised India, Sri Lanka, Pakistan,
and Morocco. One study was conducted in a low-income country (Sierra Leone).
3.1. Disinfection Type
Manually applied disinfectant application methods included mopping, wiping, pour-
ing, or spraying, using, e.g., cotton, microfiber, or pre-moistened cloths, wipes, mops.
Alcohol disinfection, including some disinfectants with multiple active ingredients (e.g.,
chlorhexidine gluconate, QAC), was identified in 11% of studies [49–68]. Peroxygen disin-
fection, including hydrogen peroxide, peracetic acid, or peroxymonosulfate, was identified
in 9% of studies [50,56,57,69–82]. QAC disinfection, which included diverse active ingre-
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dients such as primarily didecyl dimethyl ammonium chloride and benzyl ammonium
chloride, was identified in 25% of studies [20,31,44,49,52,59,63,64,69,73,75,79,80,83–113].
Sodium hypochlorite disinfection, which comprised any disinfection method specified as
bleach or sodium hypochlorite, was identified in 19% of studies
[20,44,60,61,75,89,95,97,100,104,109,114–135]. Other chlorine disinfectants were identified
in 14% of studies [65,70,78,101,118,135–154]. Other chlorines included demand-release
chlorines such as sodium dichloroisocyanurate, chloramine, chlorine-dioxide, and bromo-
chloro-dimethyl-hydantoin, as well as electrolyzed water, hypochlorous acid, and any
unspecified chlorine-based disinfectant. All other manually applied disinfectants, which
included phenols, hydrochlorides, aldehydes, copper, glucopratamin, triethylene glycol,
and grapefruit seed extract, were identified in 10% of studies [49,55,57,84,136,145,155–166].
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Figure 2. PRISMA flowchart of systematic review.
For surface interventions, we found that copper surfaces were in 9% of
studies [90,132,152,154,167–179]. Other non-copper surface applicatio s or coatings com-
pri ed 8% of tudi s [87,102,180–192]. Other non-copper surfaces included coatings incor-
porating metals such as titanium oxide and silver ions as well as other coatings comprised
of polymers, isopropyl alcohol and organofunctional silane, organosilane products, silicon
nano-coating inorganic metal and organic quaternary ammonium, silicone quaternary
amine, quaternary ammonium silyl oxide, and titanyl oxide moieties. One study used a
probiotic-based cleaning product.
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Table 1. Study characteristics.
Characteristic n (%)
Number of Studies
Total number of studies included 181 (100%)
Studies with organism outcomes 168 (93%)
Studies with HAI outcomes 28 (15%)
Country Income
High income 156 (86%)
Upper-middle income 18 (10%)
Lower-middle income 6 (3%)
Low income 1 (1%)
Study Design 2
Controlled crossover 9 (5%)
Other controlled study 78 (46%)
Uncontrolled (no contemporary control) 81 (48%)
Outcome Measurement 1,2
Concentration 106 (63%)
Percent surfaces 72 (43%)






Quaternary ammonium compounds 45 (25%)
Sodium hypochlorite 34 (19%)
Other chlorine 25 (14%)
Other manually applied 18 (10%)
Surface
Copper 17 (9%)
Other surfaces 15 (8%)
Vapor
Hydrogen peroxide vapor 33 (18%)
Other vapors 18 (10%)
Outcome Organism 1,2
All viable organisms 111 (66%)
Gram-positive bacilli 34 (20%)
Gram-positive cocci/other 63 (38%)
Gram-negative bacteria 42 (25%)
Fungi 11 (7%)
Virus 3 (2%)
Antibiotic-resistant organism 56 (33%)
1 % >100 because multiple organisms, outcomes, and/or interventions can be reported within one study. 2 Percentages of studies with
outcome organisms only (total n = 168).
Vapor disinfection includes systems described as producing and dispersing vapors,
aerosols, or droplets of disinfectants through spray, mist, or fogging machines. Hydro-
gen peroxide vapor was identified in 18% of studies [70,72,77,85,86,99,111,117,122,125,
129,130,141,142,193–211]. Other vaporized disinfection methods, which included chlo-
rine dioxide, sodium hypochlorite, essential oils, formalin, QACs, glutaral, beta propi-
olactone, steam, acidic electrolytic water, ozone, and steam, were identified in 10% of
studies [70,84,137,203,212–223].
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3.2. Outcomes
Of the 181 studies included, 168 (93%) assessed organisms on environmental surfaces
(Figure 3). Many studies described multiple outcomes and multiple intervention types. Of
the included studies, the outcome organisms that were reported were usually all viable
organisms (66%) or Gram-positive cocci (38%), followed by Gram-negative bacteria (25%),
Gram-positive bacilli (20%), and fungi (7%). Three studies (2%) assessed the disinfectant
efficacy on environmental surfaces for viruses in situ. Antibiotic-resistant organisms
were assessed in 33% of the studies, most commonly MRSA, VRE, carbapenem-resistant
Acitenobacter baumannii, extended-spectrum beta-lactamase (ESBL)-producing organisms,
and other antibiotic-resistant Gram-negative organisms.
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come (Gram-positive organisms (bacilli and cocci), Gram-negative organisms, fungi, all 
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methods, and results for all studies organized by disinfection type, and outcome organ-
isms are listed in Supplementary Material 5. 
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In this review we catalogued studies that assessed the in situ efficacy of disinfectants 
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dated framework for ideal disinfection that includes all disinfection types and not only 
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Figure 3. Number of studies with the indicated outcome organism or healthcare-associated infection and the indicated
intervention type. A darker shade indicates more studies with the indicated outcome and intervention type.
Most studies assessing all viable bacteria measured concentration, though when
assessing specific orga isms, the outco e was more commonly percent surface positive.
Overall, 63% of studies r ported concentration outcomes, 43% reported percent surface
positive, 6% reported ATP or qualitative outcomes, and 2% reported outcomes related to
gene abundance.
Of the 181 studies included, 28 (15%) reported HAI outcomes due to an environ-
mental surface disinfection intervention, and 11 of the 28 HAI studies assessed drug-
resistant organisms.
3.3. Disinfection Efficacy
Efficacy was defined differently among the included studies and was reported by
comparing reduction, prevalence ratio, mean, median, range, and/or qualitative assess-
ment. The intervention was not always compared to a control or another intervention with
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respect to statistical significance nor with respect to measures of variance and confidence
intervals. Outcome measurements included concentration, gene abundance, percent sur-
faces positive, and ATP bioluminescence (Table 1). Studies used different comparators,
with some studies comparing a disinfectant to a control without disinfectant and others to
another disinfectant.
Efficacy for each of the ten disinfection interventions is presented by different outcome
(Gram-positive organisms (bacilli and cocci), Gram-negative organisms, fungi, all viable
organisms, and HAIs) in Supplementary Material 4. The study setting, intervention
methods, and results for all studies organized by disinfection type, and outcome organisms
are listed in Supplementary Material 5.
3.4. Proposed Framework for Ideal Disinfection
In this review we catalogued studies that assessed the in situ efficacy of disinfectants
on environmental surfaces. However, the disinfectant efficacy on target organisms is not
the only consideration for the effective disinfection of environmental surfaces. Building on
the framework identifying properties for the ideal disinfectant [41], we propose an updated
framework for ideal disinfection that includes all disinfection types and not only chemical
disinfectants. The proposed decision-making framework for the ideal disinfectant includes
nine criteria categorized under three themes: fit for purpose, safety, and implementation
(Table 2).
Table 2. Proposed framework for ideal disinfection as part of a larger infection prevention and
control strategy.
Fit for Purpose
1. Veracity of disinfectant kill claim on target organism.
2. Dry surface persistence and longevity of disinfectant.
3. Efficacy of disinfectant with biofilm/organic material.
Safety
4. Chemical or antimicrobial resistance resulting from disinfectant.
5. Toxicity to healthcare workers or patients resulting from disinfectant.
6. Surface degradation resulting from disinfectant.
Implementation
7. Adherence to disinfection protocol.
8. Appropriate disinfection application.
9. Costs of disinfectant installation, application, and/or repair.
The fit for purpose criteria allow the healthcare facility to identify disinfection needs
based on, for example, critical care setting or pathogen. This systematic review rig-
orously catalogues evidence concerning the first question regarding disinfection effi-
cacy. Other questions include the persistence or residual effect of the disinfectants that
are more commonly studied among surface and vapor disinfectant interventions than
among manually applied disinfectants (see, e.g., [63,64,102,103,132,166,180], the efficacy
of the disinfectant when in the presence of increased biofilm or organic material (see,
e.g., [49,56,110,145,197,201]), and whether pre-cleaning is needed (see, e.g., [123,141,193]).
Safety criteria ensure that the disinfectant does not have unintended side effects. We
identified themes around disinfectants contributing to chemical or antimicrobial resistance
(e.g., [44,62,69,110,158]) and toxicity or discomfort to healthcare workers and patients (see,
e.g., [49,134,135,137,145,164,165,182,196,213,219,220,222]) as well as the compatibility of
the disinfectant on surfaces and clothing (see, e.g., [61,69,83,85,139,145,172,189,220]).
Many articles included themes around the implementation of disinfection interven-
tions. Specific themes were related to the adherence to the protocol, the appropriate
application of the disinfectant, and the costs. Adherence was discussed as being related
to monitoring and training. Studies assessing disinfection implementation found that
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objective measurements of disinfection (e.g., ATP fluorescence or environmental samples
rather than visual inspection) improved disinfection practices [28,153].
Monitoring for disinfection compliance was primarily conducted through biological
indicators for HPV interventions [194,199,201,209] and by using fluorescent markers or ran-
dom audits [62,69,114,135,153]. Implementation may be affected by the inappropriate ap-
plication of the protocol related to disinfectant contact time or improper disinfectant concen-
tration (see, e.g., [61,78,153]) or whether implementation improved or worsened due to the
method of application (e.g., wipes vs. mop; cotton vs. microfiber; one cloth vs. two cloths;
see, e.g., [62,92,104,107,153,165]). Some antimicrobial coatings may not bind appropriately
to target surfaces, and this may decrease the apparent efficacy. Training environmental ser-
vices staff before and during interventions were identified as important for both adherence
to protocol and to the appropriate application of the disinfectant (see, e.g., [20,78,120,125]).
Few studies mentioned costs although some reported monetary or time costs associated
with a disinfectant type (see, e.g., [69,70,92,114,126,131,137,141,160,197,201,223]).
3.5. Study Quality
Studies primarily used a before-after design without a simultaneous control (48%) or
controlled cohort/controlled before-after study designs (46%). Few studies had crossover
designs (5%) (Table 1).
The average score for each of fourteen study quality indicators is displayed in Figure 4.
Results of the 14-point study quality assessment for each study are listed in Supplementary
Material 2, Table S7. A summary table of the proportions of studies that received each study
quality criterion for each study quality indicator appears in Supplementary Material 2,
Table S5.
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Frequent weaknesses in study quality concerned implementation, reporting, and
analysis. Most (90%) studies did not report whether there were missing data in the analyses,
and 85% did not report blind evaluation of both healthcare workers and microbiologists.
Only 13% reported blind evaluation in either group. Half (52%) of the studies did not
sufficiently identify the disinfectant (e.g., product active ingredients and concentration),
67% of studies did not report measures of variance nor conduct a statistical test, 38% of
studies measured the implementation of the disinfection intervention through, e.g., ATP
assays, 23% indicated that the staff were trained but that intervention was not monitored,
and 38% did not discuss monitoring or training during the intervention. Finally, 45% of
the studies had funding other than academic or government sources and did not include
a statement of influence or conflicts of interest regarding funding contributions to study
design, implementation, decision to publish, etc.
The validation of the study quality instrument revealed a Cohen’s kappa coefficient of
0.75 (95% confidence interval 0.70–0.80) for agreeability between scoring by initial reviewers
compared to scoring by the second independent reviewer (i.e., 70–80% of the scores can
be attributed to reliable scoring by instrument users, and 20–30% can be attributed to
random chance, error, or other factors). The raw percent agreement was calculated since
the reviewers were trained, and low randomness due to guessing was expected. The raw
percent agreement was 84%. The Cohen’s kappa suggests moderate inter-rater reliability,
and the raw percent agreement suggests strong inter-rater reliability for scoring [47].
We interpreted the variability among indicator score variability as the degree to which
the indicator could be easily interpreted for the study. Cohen’s kappa and raw percent
agreement for each study quality indicator are in Supplementary Material 2, Table S8.
4. Discussion
In this evidence map and systematic review, we identified 181 studies that described
disinfection interventions on environmental surfaces across ten types of disinfection groups.
We compared disinfectant interventions with respect to study design, outcome organism,
and study quality; however, comparing disinfectant efficacy was difficult due to the hetero-
geneity in the study design and the unmeasured variability in disinfection implementation.
4.1. Strengths and Weaknesses
This systematic review identified important gaps in study design and study reporting
for studies describing the efficacy of disinfection on environmental surfaces. Studies from
low- and lower-middle income countries comprised only 4% of the included studies. Study
design flaws affecting many studies included the omission of contemporary controls and
only used a historical control. For the studies that did use a contemporary control (e.g.,
cohort study or controlled before-after), many did not report the initial concentration when
comparing reductions or disinfection efficacy across two experimental groups. Among
studies reporting initial concentration, few assessed and corrected for different initial
concentrations between groups (see, e.g., [126]). Confounders identified in the studies
included the differential use of cleaning or disinfection by the experimental group (e.g., re-
searchers vs. healthcare services; trained nurses vs. outsourced cleaning team), differential
implementation of disinfection strategy (no monitoring of implementation), differential or
unclear sample collection time relative to routine or standard cleaning/disinfection, and
no baseline equivalence of the outcome (initial burden not measured on control compared
to intervention surfaces). The lack of monitoring and the audit of environmental services
and disinfection implementation is a determinant that was not measured in most studies
and has been identified in other systematic reviews of IPC as an important determinant
for effective disinfection [19,28]. The best study designs compared the concentration of
the outcome organism before and after disinfection intervention and before and after a
contemporary control in equivalent healthcare settings.
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4.2. Disinfection Efficacy
Many studies inadequately described the disinfection intervention (active ingredient,
contact times, and final dilutions for disinfectants used in intervention studies). The
method of application is important. Contact time may be affected by different methods of
implementation (e.g., wet mopping vs. spray mopping; cotton vs. microfiber cloths) (see,
e.g., [62,92,107,153,165]).
The outcomes that were measured were primarily on all viable organisms, specifically
bacteria; only three studies assessed viruses, and eleven assessed fungi. Many studies
did not assess concentration but rather the prevalence of surfaces that were positive for
an organism. For pathogens of concern, most studies reported prevalence rather than
concentration, and as a result, many may not have observed reductions, which is probably
due to the low initial burden of the pathogen. More studies that reported all of the viable
bacteria outcomes found significant effects compared to studies that reported other outcome
organisms, which is possibly due to fewer studies assessing concentration among specific
pathogens (see, e.g., [182]). Large sample sizes are necessary to assess significant reductions
of low-prevalence pathogens; alternatively, studies that inoculate high concentrations of
pathogens may elicit a better understanding of disinfectant efficacy.
4.3. Healthcare-Associated Infections
The identified studies have provided extensive evidence that environmental surfaces
can be colonized with HAI-related pathogens after disinfection and that these surfaces
could be an important transmission pathway, with some pathogens surviving prescribed
disinfection. HAIs caused by antimicrobial-resistant organisms were assessed less often.
It is estimated that 426,277 healthcare-associated infections are caused by antimicrobial-
resistant microorganisms every year in the European Union [224]. Antimicrobial-resistant
organisms present a challenge for treatment and can lead to increased morbidity and
mortality, as they have a higher burden in low and middle income countries due to delayed
presentation, low access to microbiological diagnostics and testing, and the low availability
of second-line antibiotics [225]. Disinfection interventions on environmental surfaces may
reduce HAIs; however, disinfection efficacy is only one component in a larger system of
IPC strategies that are applicable to environmental surfaces.
5. Conclusions
Comparing disinfection efficacy was impeded by study heterogeneity and study
quality. As such, we conclude that guidelines for disinfectant use are primarily based
on laboratory data rather than on a systematic review of in situ disinfection efficacy. We
built upon the framework of the criteria for the selection of the ideal disinfectant to review
important components for system-level disinfection efficacy as part of infection prevention
and control (IPC) strategies.
In addition to disinfection efficacy, bundled interventions, including monitoring and
implementation interventions such as measuring environmental bioburden, audit and feed-
back, training/re-education of environmental services staff, the addition of more cleaning
staff or supervisors, and/or the use of implementation or quality checklists can improve
IPC efficacy [226]. Monitoring/audit and feedback programs can prevent and control HAIs
and antimicrobial resistance by supporting behavior changes during IPC implementation
to create a monitoring and learning culture (as recommended in WHO 2018 [226]). Evi-
dence deemed as being high-quality is reported to indicate that surveillance with active
feedback may reduce HAIs [25]. A separate systematic review found intermediate-level
evidence that standardizing audits and feedback reduces HAIs [227]. Studies reporting
the sustainability of implementation interventions highlight the importance of ongoing
education, direct feedback, and fiscal commitment to the monitoring/audit and feedback
program from administrators [28].
Contextual factors for successful disinfection implementation include placing envi-
ronmental services within the administrative hierarchy of the hospital, the outsourcing of
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environmental services, and a positive patient safety culture between clinical and environ-
mental services staff and between supervisors and front-line personnel [28]. Multimodal
strategies, including team-based, task-oriented, positive, and hands-on training, were
considered to be more effective than formal training for IPC program adherence [227].
While implementation research has found that training, monitoring, and feedback of IPC
implementation increases adherence to IPC programs, evidence about the long-term effi-
cacy of IPC interventions is still needed [228]. As such, a complex of factors determines
IPC effectiveness. While the choice of disinfectant and its efficacy have been dominant
considerations in research and IPC programs, it is critically important for practitioners and
researchers to consider system-level efficacy in reducing organism load and reducing HAIs
in healthcare settings.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/ijerph182111100/s1, Supplementary Material 1: Database Search Strategies; Supplementary
Material 2: List of Included Studies and Study Quality Assessment; Supplementary Material 3:
PRISMA Checklists; Supplementary Material 4: Summary of Disinfection Intervention Efficacy;
Supplementary Material 5: Tables for Disinfection Efficacy by Disinfection Intervention and Outcome
Author Contributions: Conceptualization, J.B. and R.C.; methodology, E.C.C., C.K.C., M.C., K.G.,
G.P., D.F., and R.C.; software, K.G., M.C., and G.P.; validation, E.C.C. and D.F.; formal analysis, E.C.C.;
investigation, H.A., A.B., E.B., E.C.C., G.C., C.H., K.H., E.J.G., T.J., S.M., and Y.S.; resources, J.B.; data
curation, H.A., A.B., E.B., E.C.C., G.C., C.H., K.H., E.J.G., T.J., S.M., and Y.S.; writing—original draft
preparation, E.C.C.; writing—review and editing, E.C.C., R.C., M.C., C.K.C., and J.B.; visualization,
E.C.C.; supervision, J.B., R.C., and E.C.C.; project administration, E.C.C.; funding acquisition, J.B. All
authors have read and agreed to the published version of the manuscript.
Funding: This research was funded by a gift from Kersia Group to the Water Institute at the University
of North Carolina for research related to disinfection in health care settings. Collin Knox Coleman
was supported in part by a grant from the National Institute of Environmental Health Sciences
(T32ES007018).
Institutional Review Board Statement: Not applicable.
Informed Consent Statement: Not applicable.
Data Availability Statement: All supporting data are in the Supplementary Materials.
Conflicts of Interest: The authors declare no conflict of interest. Kersia Group contributed to the
scope of the research project and study design but had no role in study implementation, data
collection, analyses, interpretation of the data, preparation of the manuscript, or decision to publish.
References
1. Magill, S.S.; O’Leary, S.; Thompson, D.; Dumyati, G.; Nadle, J.; Wilson, L.; Kainer, M.; Lynfield, R.; Greissman, S.; Ray, S.; et al.
Changes in Prevalence of Health Care–Associated Infections. N. Engl. J. Med. 2018, 380, 1085–1086.
2. Cassini, A.; Plachouras, D.; Eckmanns, T.; Abu Sin, M.; Blank, H.-P.; Ducomble, T.; Haller, S.; Harder, T.; Klingeberg, A.;
Sixtensson, M.; et al. Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based
Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study. PLoS Med. 2016, 13, e1002150. [CrossRef]
3. Allegranzi, B.; Nejad, S.B.; Combescure, C.; Graafmans, W.; Attar, H.; Donaldson, L.; Pittet, D. Burden of endemic health-care-
associated infection in developing countries: Systematic review and meta-analysis. Lancet 2011, 377, 228–241. [CrossRef]
4. Curcio, D.; Cane, A.; Fernández, F.; Correa, J. Surgical site infection in elective clean and clean-contaminated surgeries in
developing countries. Int. J. Infect. Dis. 2019, 80, 34–45. [CrossRef]
5. Bonell, A.; Azarrafiy, R.; Huong, V.T.L.; Le Viet, T.; Phu, V.D.; Dat, V.Q.; Wertheim, H.; Van Doorn, H.R.; Lewycka, S.; Nadjm, B. A
Systematic Review and Meta-analysis of Ventilator-associated Pneumonia in Adults in Asia: An Analysis of National Income
Level on Incidence and Etiology. Clin. Infect. Dis. 2019, 68, 511–518. [CrossRef] [PubMed]
6. Vickery, K.; Deva, A.; Jacombs, A.; Allan, J.; Valente, P.; Gosbell, I.B. Presence of biofilm containing viable multiresistant organisms
despite terminal cleaning on clinical surfaces in an intensive care unit. J. Hosp. Infect. 2012, 80, 52–55. [CrossRef]
7. Weiner-Lastinger, L.M.; Abner, S.; Edwards, J.R.; Kallen, A.J.; Karlsson, M.; Magill, S.S.; Pollock, D.; See, I.; Soe, M.M.; Walters,
M.S.; et al. Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported
to the National Healthcare Safety Network, 2015–2017. Infect. Control Hosp. Epidemiol. 2020, 41, 1–18. [CrossRef] [PubMed]
8. Lessa, F.C.; Mu, Y.; Bamberg, W.M.; Beldavs, Z.G.; Dumyati, G.K.; Dunn, J.R.; Farley, M.M.; Holzbauer, S.M.; Meek, J.I.; Phipps,
E.C.; et al. Burden of Clostridium difficile Infection in the United States. N. Engl. J. Med. 2015, 372, 825–834. [CrossRef] [PubMed]
Int. J. Environ. Res. Public Health 2021, 18, 11100 14 of 22
9. Donskey, C.J. Beyond high-touch surfaces: Portable equipment and floors as potential sources of transmission of health care–
associated pathogens. Am. J. Infect. Control. 2019, 47, A90–A95. [CrossRef] [PubMed]
10. Ansari, S.A.; Sattar, S.A.; Springthorpe, V.S.; Wells, G.A.; Tostowaryk, W. Rotavirus survival on human hands and transfer of
infectious virus to animate and nonporous inanimate surfaces. J. Clin. Microbiol. 1988, 26, 1513–1518. [CrossRef] [PubMed]
11. Ansari, S.A.; Springthorpe, V.S.; Sattar, S.A.; Rivard, S.; Rahman, M. Potential role of hands in the spread of respiratory viral
infections: Studies with human parainfluenza virus 3 and rhinovirus 14. J. Clin. Microbiol. 1991, 29, 2115–2119. [CrossRef]
12. Mbithi, J.N.; Springthorpe, V.S.; Boulet, J.R.; Sattar, S.A. Survival of hepatitis A virus on human hands and its transfer on contact
with animate and inanimate surfaces. J. Clin. Microbiol. 1992, 30, 757–763. [CrossRef]
13. Wu, Y.-L.; Yang, X.-Y.; Ding, X.-X.; Li, R.-J.; Pan, M.-S.; Zhao, X.; Hu, X.-Q.; Zhang, J.-J.; Yang, L.-Q.; Yang, X.-Y. Exposure to
infected/colonized roommates and prior room occupants increases the risks of healthcare-associated infections with the same
organism. J. Hosp. Infect. 2019, 101, 231–239. [CrossRef] [PubMed]
14. Cohen, B.; Cohen, C.C.; Løyland, B.; Larson, E.L. Transmission of health care-associated infections from roommates and prior
room occupants: A systematic review. Clin. Epidemiol. 2017, 9, 297–310. [CrossRef] [PubMed]
15. Huang, S.S.; Datta, R.; Platt, R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch. Intern. Med. 2006,
166, 1945–1951. [CrossRef]
16. Shaughnessy, M.K.; Micielli, R.L.; DePestel, D.D.; Arndt, J.; Strachan, C.L.; Welch, K.B.; Chenoweth, C.E. Evaluation of Hospital
Room Assignment and Acquisition of Clostridium difficile Infection. Infect. Control Hosp. Epidemiol. 2011, 32, 201–206. [CrossRef]
[PubMed]
17. Nseir, S.; Blazejewski, C.; Lubret, R.; Wallet, F.; Courcol, R.; Durocher, A. Risk of acquiring multidrug-resistant Gram-negative
bacilli from prior room occupants in the intensive care unit. Clin. Microbiol. Infect. 2011, 17, 1201–1208. [CrossRef]
18. Carling, P.C.; Parry, M.M.; Rupp, M.E.; Po, J.L.; Dick, B.; Von Beheren, S. Improving Cleaning of the Environment Surrounding
Patients in 36 Acute Care Hospitals. Infect. Control Hosp. Epidemiol. 2008, 29, 1035–1041. [CrossRef]
19. Donskey, C.J. Does improving surface cleaning and disinfection reduce health care-associated infections? Am. J. Infect. Control
2013, 41, S12–S19. [CrossRef]
20. Eckstein, B.C.; Adams, D.A.; Eckstein, E.C.; Rao, A.; Sethi, A.K.; Yadavalli, G.K.; Donskey, C.J. Reduction of Clostridium difficile and
vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods.
BMC Infect. Dis. 2007, 7, 61. [CrossRef]
21. Hota, B.; Blom, D.W.; Lyle, E.A.; Weinstein, R.A.; Hayden, M.K. Interventional evaluation of environmental contamination by
vancomycin-resistant enterococci: Failure of personnel, product, or procedure? J. Hosp. Infect. 2009, 71, 123–131. [CrossRef]
22. Po, J.L.; Burke, R.; Sulis, C.; Carling, P.C. Dangerous cows: An analysis of disinfection cleaning of computer keyboards on wheels.
Am. J. Infect. Control. 2009, 37, 778–780. [CrossRef] [PubMed]
23. Creamer, E.; Dorrian, S.; Dolan, A.; Sherlock, O.; Fitzgerald-Hughes, D.; Thomas, T.; Walsh, J.; Shore, A.; Sullivan, D.; Kinnevey, P.;
et al. When are the hands of healthcare workers positive for meticillin-resistant Staphylococcus aureus? J. Hosp. Infect. 2010, 75,
107–111. [CrossRef] [PubMed]
24. Weber, D.J.; Anderson, D.; Rutala, W.A. The role of the surface environment in healthcare-associated infections. Curr. Opin. Infect.
Dis. 2013, 26, 338–344. [CrossRef]
25. Price, L.; MacDonald, J.; Melone, L.; Howe, T.; Flowers, P.; Currie, K.; Curran, E.; Ness, V.; Waddell, D.; Manoukian, S.; et al.
Effectiveness of national and subnational infection prevention and control interventions in high-income and upper-middle-income
countries: A systematic review. Lancet Infect. Dis. 2018, 18, e159–e171. [CrossRef]
26. Louh, I.K.; Greendyke, W.G.; Hermann, E.A.; Davidson, K.W.; Falzon, L.; Vawdrey, D.K.; Shaffer, J.A.; Calfee, D.P.; Furuya, E.Y.;
Ting, H.H.; et al. Clostridium Difficile Infection in Acute Care Hospitals: Systematic Review and Best Practices for Prevention.
Infect. Control Hosp. Epidemiol. 2017, 38, 476–482. [CrossRef] [PubMed]
27. McDonald, L.C.; Arduino, M. Editorial commentary: Climbing the evidentiary hierarchy for environmental infection control.
Clin. Infect. Dis. 2013, 56, 36–39. [CrossRef]
28. Han, J.H.; Sullivan, N.; Leas, B.F.; Pegues, D.A.; Kaczmarek, J.L.; Umscheid, C.A. Cleaning hospital room surfaces to prevent
health care-associated infections: A technical brief. Ann. Intern. Med. 2015, 163, 598–607. [CrossRef]
29. ASTM International. ASTM E2197—02 Standard Quantitative Disk Carrier Test Method for Determining the Bactericidal, Virucidal,
Fungicidal, Mycobactericidal and Sporicidal Activities of Liquid Chemical Germicides; ASTM International: West Conshohocken, PA,
USA, 2002.
30. Sattar, S.A.; Springthorpe, V.S.; Adegbunrin, O.; Zafer, A.A.; Busa, M. A disc-based quantitative carrier test method to assess the
virucidal activity of chemical germicides. J. Virol. Methods 2003, 112, 3–12. [CrossRef]
31. Le Coutour, C.; Oblin, I. Disinfection of surfaces in hospital: Comparison between theoric and real efficiency of three commercial
products. Tech. Hosp. Med.-Soc. Sanit. 1991, 46, 49–50.
32. Neely, A.N.; Maley, M.P. Survival of enterococci and staphylococci on hospital fabrics and plastic. J. Clin. Microbiol. 2000, 38, 724–726.
[CrossRef]
33. Noskin, G.A.; Stosor, V.; Cooper, I.; Peterson, L.R. Recovery of Vancomycin-Resistant Enterococci on Fingertips and Environmental
Surfaces. Infect. Control Hosp. Epidemiol. 1995, 16, 577–581. [CrossRef] [PubMed]
34. Traoré, O.; Springthorpe, V.S.; Sattar, S.A. A quantitative study of the survival of two species of Candida on porous and non-porous
environmental surfaces and hands. J. Appl. Microbiol. 2002, 92, 549–555. [CrossRef] [PubMed]
Int. J. Environ. Res. Public Health 2021, 18, 11100 15 of 22
35. Scott, H.; Campbell, L.; Harvey, R.; Bischoff, K.; Alali, W.; Barling, K.; Anderson, R. Patterns of Antimicrobial Resistance among
Commensal Escherichia coli Isolated from Integrated Multi-Site Housing and Worker Cohorts of Humans and Swine. Foodborne
Pathog. Dis. 2005, 2, 24–37. [CrossRef]
36. Leas, B.; Sullivan, N.; Han, J.; Pegues, D.; Kaczmarek, J.; Umscheid, C. Environmental Cleaning for the Prevention of Healthcare-
Associated Infections. Agency Healthc. Res. Qual. 2015, 22, 121.
37. Schreiber, P.W.; Sax, H.; Wolfensberger, A.; Clack, L.; Kuster, S.P. The preventable proportion of healthcare-associated infections
2005–2016: Systematic review and meta-analysis. Infect. Control Hosp. Epidemiol. 2018, 39, 1277–1295. [CrossRef] [PubMed]
38. Doll, M.; Stevens, M.; Bearman, G. Environmental cleaning and disinfection of patient areas. Int. J. Infect. Dis. 2018, 67, 52–57.
[CrossRef] [PubMed]
39. Rutala, W.A.; Weber, D.J. Selection of the Ideal Disinfectant. Hosp. Epidemiol. 2014, 35, 855–865. [CrossRef] [PubMed]
40. U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC). Guidelines for Environmental
Infection Control in Health-Care Facilities Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
(HICPAC); CDC: Atlanta, GA, USA, 2019.
41. Rutala, W.A.; Weber, D.J. Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008. Available online: https:
//stacks.cdc.gov/view/cdc/47378 (accessed on 15 December 2019).
42. World Health Organization. Prevention of Hospital-Acquired Infections: A Practical Guide, 2nd ed.; World Health Organization:
Geneva, Switzerland, 2002.
43. Varghese, A.; Cawley, M.; Hong, T. Supervised clustering for automated document classification and prioritization: A case study
using toxicological abstracts. Environ. Syst. Decis. 2018, 38, 398–414. [CrossRef]
44. Yuen, J.W.M.; Chung, T.W.K.; Loke, A.Y. Methicillin-Resistant Staphylococcus aureus (MRSA) contamination in bedside surfaces of
a hospital ward and the potential effectiveness of enhanced disinfection with an antimicrobial polymer surfactant. Int. J. Environ.
Res. Public Health. 2015, 12, 3026–3041. [CrossRef]
45. World Bank. World Bank Country and Lending Groups—World Bank Data Help Desk. Available online: https://datahelpdesk.
worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups (accessed on 11 January 2021).
46. NIH Study Quality Assessment Tools. Available online: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-
tools (accessed on 11 January 2021).
47. McHugh, M.L. Interrater reliability: The kappa statistic. Biochem. Med. 2012, 22, 276–282. [CrossRef]
48. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.;
Brennan, S.E.; et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PLoS Med. 2021, 18, n71.
[CrossRef]
49. Fujii, M. Prevention of MRSA infection in neurosurgery: Examination from the patient environment. No Shinkei Geka. 1996, 24,
241–245.
50. Fukada, T.; Tsuchiya, Y.; Iwakiri, H.; Ozaki, M. Adenosine triphosphate bioluminescence assay for monitoring contamination
of the working environment of anaesthetists and cleanliness of the operating room. J. Infect. Prev. 2015, 16, 8–13. [CrossRef]
[PubMed]
51. Fukada, T.; Iwakiri, H.; Ozaki, M. Anaesthetists’ role in computer keyboard contamination in an operating room. J. Hosp. Infect.
2008, 70, 148–153. [CrossRef] [PubMed]
52. Evans, M.W.; Breshears, J.; Campbell, A.; Husbands, C.; Rupert, R. Assessment and risk reduction of infectious pathogens on
chiropractic treatment tables. Chiropr. Osteopat. 2007, 15, 8. [CrossRef] [PubMed]
53. Ferreira, A.M.; de Andrade, D.; Rigotti, M.A.; de Almeida, M.T.G.; Guerra, O.G.; dos Santos, A.G., Jr. Assessment of disinfection
of hospital surfaces using different monitoring methods. Rev. Lat. Am. Enfermagem. 2015, 23, 466–474. [CrossRef] [PubMed]
54. Dramowski, A.; Whitelaw, A.; Cotton, M.F. Assessment of terminal cleaning in pediatric isolation rooms: Options for low-resource
settings. Am. J. Infect. Control. 2016, 44, 1558–1564. [CrossRef] [PubMed]
55. Oie, S.; Yanagi, C.; Matsui, H.; Nishida, T.; Tomita, M.; Kamiya, A. Contamination of environmental surfaces by Staphylococcus
aureus in a dermatological ward and its preventive measures. Biol. Pharm. Bull. 2005, 28, 120–123. [CrossRef] [PubMed]
56. Doidge, M.; Allworth, A.M.; Woods, M.; Marshall, P.; Terry, M.; Brien, K.O.; Goh, H.M.; George, N.; Nimmo, G.R.; Schembri, M.A.;
et al. Control of an Outbreak of Carbapenem—Resistant Acinetobacter baumannii in Australia after Introduction of Environmental
Cleaning with a Commercial Oxidizing Disinfectant. Infect. Control Hosp. Epidemiol. 2010, 31, 17–20. [CrossRef] [PubMed]
57. Biswal, M.; Rudramurthy, S.; Jain, N.; Shamanth, A.; Sharma, D.; Jain, K.; Yaddanupudi, L.; Chakrabarti, A. Controlling a possible
outbreak of Candida auris infection: Lessons learnt from multiple interventions. J. Hosp. Infect. 2017, 97, 363–370. [CrossRef]
[PubMed]
58. Sui, Y.S.; Wan, G.H.; Chen, Y.W.; Ku, H.L.; Li, L.P.; Liu, C.H.; Mau, H.S. Effectiveness of bacterial disinfectants on surfaces of
mechanical ventilator systems. Respir. Care 2012, 57, 250–256. [CrossRef] [PubMed]
59. Codish, S.; Toledano, R.; Novack, V.; Sherf, M.; Borer, A. Effectiveness of stringent decontamination of computer input devices
in the era of electronic medical records and bedside computing: A randomized controlled trial. Am. J. Infect. Control. 2015, 43,
644–646. [CrossRef] [PubMed]
60. Casini, B.; Selvi, C.; Cristina, M.L.; Totaro, M.; Costa, A.L.; Valentini, P.; Barnini, S.; Baggiani, A.; Tagliaferri, E.; Privitera, G.
Evaluation of a modified cleaning procedure in the prevention of carbapenem-resistant Acinetobacter baumannii clonal spread in a
burn intensive care unit using a high-sensitivity luminometer. J. Hosp. Infect. 2017, 95, 46–52. [CrossRef]
Int. J. Environ. Res. Public Health 2021, 18, 11100 16 of 22
61. Alhmidi, H.; Koganti, S.; Cadnum, J.L.; Rai, H.; Jencson, A.L.; Donskey, C.J. Evaluation of a novel alcohol-based surface
disinfectant for disinfection of hard and soft surfaces in healthcare facilities. Open Forum Infect. Dis. 2017, 4, 8–10. [CrossRef]
62. Andersen, B.M.; Rasch, M.; Kvist, J.; Tollefsen, T.; Lukkassen, R.; Sandvik, L.; Welo, A. Floor cleaning: Effect on bacteria and
organic materials in hospital rooms. J. Hosp. Infect. 2008, 71, 57–65. [CrossRef]
63. Schmidt, M.G.; Fairey, S.E.; Attaway, H.H. In situ evaluation of a persistent disinfectant provides continuous decontamination
within the clinical environment. Am. J. Infect. Control 2019, 47, 732–734. [CrossRef]
64. Attaway, H.H.; Fairey, S.; Steed, L.L.; Salgado, C.D.; Michels, H.T.; Schmidt, M.G. Intrinsic bacterial burden associated with
intensive care unit hospital beds: Effects of disinfection on population recovery and mitigation of potential infection risk. Am. J.
Infect. Control. 2012, 40, 907–912. [CrossRef] [PubMed]
65. Jones, R.; Hutton, A.; Mariyaselvam, M.; Hodges, E.; Wong, K.; Blunt, M.; Young, P. Keyboard cleanliness: A controlled study of
the residual effect of chlorhexidine gluconate. Am. J. Infect. Control. 2015, 43, 289–291. [CrossRef] [PubMed]
66. Reynolds, K.A.; Sexton, J.D.; Pivo, T.; Humphrey, K.; Leslie, R.A.; Gerba, C.P. Microbial transmission in an outpatient clinic and
impact of an intervention with an ethanol-based disinfectant. Am. J. Infect. Control. 2019, 47, 128–132. [CrossRef] [PubMed]
67. Zubair, M.; Imtiaz, S.; Zafar, A.; Javed, H.; Atif, M.; Abosalif, K.O.A.A.; Ejaz, H. Role of hospital surfaces in transmission of
infectious diseases. Pak. J. Med. Health Sci. 2018, 12, 857–859.
68. Bokulich, N.A.; Mills, D.A.; Underwood, M.A. Surface microbes in the neonatal intensive care unit: Changes with routine
cleaning and over time. J. Clin. Microbiol. 2013, 51, 2617–2624. [CrossRef] [PubMed]
69. Saha, A.; Botha, S.L.; Weaving, P.; Satta, G. A pilot study to assess the effectiveness and cost of routine universal use of peracetic
acid sporicidal wipes in a real clinical environment. Am. J. Infect. Control 2016, 44, 1247–1251. [CrossRef] [PubMed]
70. Doan, L.; Forrest, H.; Fakis, A.; Craig, J.; Claxton, L.; Khare, M. Clinical and cost effectiveness of eight disinfection methods for
terminal disinfection of hospital isolation rooms contaminated with Clostridium difficile 027. J. Hosp. Infect. 2012, 82, 114–121.
[CrossRef] [PubMed]
71. Armellino, D.; Goldstein, K.; Thomas, L.; Walsh, T.J.; Petraitis, V. Comparative evaluation of operating room terminal cleaning
by two methods: Focused multivector ultraviolet (FMUV) versus manual-chemical disinfection. Am. J. Infect. Control. 2020, 48,
147–152. [CrossRef] [PubMed]
72. Mitchell, B.G.; Digney, W.; Locket, P.; Dancer, S.J. Controlling methicillin-resistant Staphylococcus aureus (MRSA) in a hospital and
the role of hydrogen peroxide decontamination: An interrupted time series analysis. BMJ Open 2014, 4, 1–7. [CrossRef]
73. Carling, P.C.; Perkins, J.; Ferguson, J.; Thomasser, A. Evaluating a New Paradigm for Comparing Surface Disinfection in Clinical
Practice. Infect. Control Hosp. Epidemiol. 2014, 35, 1349–1355. [CrossRef] [PubMed]
74. Boyce, J.M.; Havill, N.L. Evaluation of a New Hydrogen Peroxide Wipe Disinfectant. Infect. Control Hosp. Epidemiol. 2013, 34,
521–523. [CrossRef]
75. Deshpande, A.; Mana, T.S.; Cadnum, J.L.; Jencson, A.C.; Sitzlar, B.; Fertelli, D.; Hurless, K.; Kundrapu, S.; Sunkesula, V.C.;
Donskey, C.J.; et al. Evaluation of a Sporicidal Peracetic Acid/Hydrogen Peroxide—Based Daily Disinfectant Cleaner. Soc. Healthc.
Epidemiol. Am. 2014, 35, 5–8. [CrossRef]
76. Wiemken, T.L.; Curran, D.R.; Kelley, R.R.; Pacholski, E.B.; Carrico, R.M.; Peyrani, P.; Khan, M.S.S.; Ramirez, J.A. Evaluation of the
effectiveness of improved hydrogen peroxide in the operating room. Am. J. Infect. Control 2014, 42, 1004–1005. [CrossRef]
77. Yui, S.; Ali, S.; Muzslay, M.; Jeanes, A.; Wilson, A.P.R. Identification of Clostridium difficile Reservoirs in the Patient Environment
and Efficacy of Aerial Hydrogen Peroxide Decontamination. Infect. Control Hosp. Epidemiol. 2017, 38, 1487–1492. [CrossRef]
[PubMed]
78. Siani, H.; Wesgate, R.; Maillard, J.Y. Impact of antimicrobial wipes compared with hypochlorite solution on environmental surface
contamination in a health care setting: A double-crossover study. Am. J. Infect. Control 2018, 46, 1180–1187. [CrossRef] [PubMed]
79. Boyce, J.M.; Guercia, K.A.; Sullivan, L.; Havill, N.L.; Fekieta, R.; Kozakiewicz, J.; Goffman, D. Prospective cluster controlled
crossover trial to compare the impact of an improved hydrogen peroxide disinfectant and a quaternary ammonium-based
disinfectant on surface contamination and health care outcomes. Am. J. Infect. Control 2017, 45, 1006–1010. [CrossRef] [PubMed]
80. Dharan, S.; Mourouga, P.; Copin, P.; Bessmer, G.; Tschanz, B.; Pittet, D. Routine disinfection of patients’ environmental surfaces.
Myth or reality? J. Hosp. Infect. 1999, 42, 113–117. [CrossRef]
81. Sjöberg, M.; Eriksson, M.; Andersson, J.; Norén, T. Transmission of Clostridium difficile spores in isolation room environments and
through hospital beds. Apmis 2014, 122, 800–803. [CrossRef]
82. Alfa, M.J.; Lo, E.; Olson, N.; Macrae, M.; Buelow-Smith, L. Use of a daily disinfectant cleaner instead of a daily cleaner reduced
hospital—Acquired infection rates. Am. J. Infect. Control 2015, 43, 141–146. [CrossRef]
83. Gonzalez, S.; Illescas, A.; Escarzaga, E. Reduction of Bacterial Contamination of the Environment of a General Hospital, by the
Use of a new Germicide Biomet 66. Rev. Med. del Hosp. Gen. 1963, 26, 873–878.
84. Strat, E. Research on the effectiveness of disinfectants in the surfactant group o the degeneration of the hospital environment. Rev.
Med. Chir. Soc. Med. Nat. Iasi. 1971, 75, 957–966.
85. Passaretti, C.L.; Otter, J.A.; Reich, N.G.; Myers, J.; Shepard, J.; Ross, T.; Carroll, K.C.; Lipsett, P.; Perl, T.M. An evaluation of
environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant
organisms. Clin. Infect. Dis. 2013, 56, 27–35. [CrossRef]
86. Otter, J.A.; Cummins, M.; Ahmad, F.; van Tonder, C.; Drabu, Y.J. Assessing the biological efficacy and rate of recontamination
following hydrogen peroxide vapour decontamination. J. Hosp. Infect. 2007, 67, 182–188. [CrossRef]
Int. J. Environ. Res. Public Health 2021, 18, 11100 17 of 22
87. Lewis, B.D.; Spencer, M.; Rossi, P.J.; Lee, C.J.; Brown, K.R.; Malinowski, M.; Seabrook, G.R.; Edmiston, C.E. Assessment of an
innovative antimicrobial surface disinfectant in the operating room environment using adenosine triphosphate bioluminescence
assay. Am. J. Infect. Control 2015, 43, 283–285. [CrossRef]
88. Suzuki, A.; Namba, Y.; Matsuura, M.; Horisawa, A. Bacterial contamination of floors and other surfaces in operating rooms: A
five-year survey. J. Hyg. 1984, 93, 559–566. [CrossRef] [PubMed]
89. Roux, D.; Aubier, B.; Cochard, H.; Quentin, R.; Van Der Mee-Marquet, N. Contaminated sinks in intensive care units: An
underestimated source of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the patient environment. J. Hosp.
Infect. 2013, 85, 106–111. [CrossRef] [PubMed]
90. Hinsa-Leasure, S.M.; Nartey, Q.; Vaverka, J.; Schmidt, M.G. Copper alloy surfaces sustain terminal cleaning levels in a rural
hospital. Am. J. Infect. Control 2016, 44, e195–e203. [CrossRef] [PubMed]
91. Furlan, M.C.R.; Ferreira, A.M.; Rigotti, M.A.; Guerra, O.G.; Frota, O.P.; De Sousa, A.F.L.; De Andrade, D. Correlation among
monitoring methods of surface cleaning and disinfection in outpatient facilities. Acta Paul. Enferm. 2019, 32, 282–289. [CrossRef]
92. Byers, K.E.; Durbin, L.J.; Simonton, B.M.; Anglim, A.M.; Adal, A.; Farr, B.M.; Control, S.I.; Epidemiology, H.; Apr, N. Disinfection
of Hospital Rooms Contaminated with Vancomycin-Resistant Enterococcus faecium. Infect. Control Hosp. Epidemiol. 2020, 19,
261–264.
93. Panknin, H. Diversity of the ambient flora and effectiveness of surface disinfection measures in the neonatal unit. Hyg. Med. 2014,
39, 245–247.
94. Kitagawa, H.; Mori, M.; Kashiyama, S.; Sasabe, Y.; Ukon, K.; Shimokawa, N.; Shime, N.; Ohge, H. Effect of pulsed xenon
ultraviolet disinfection on methicillin-resistant Staphylococcus aureus contamination of high-touch surfaces in a Japanese hospital.
Am. J. Infect. Control 2020, 48, 139–142. [CrossRef]
95. Styaningsih, N.; Suwundo, A.; Adi, M.S. Effectiveness of Disinfectant A and B on the Growth of Bacteria in the Area of Central
Surgical Installation of Hospital X in Kudus City. Indian J. Public Health Res. Dev. 2019, 10, 795–804. [CrossRef]
96. Santos, A.G., Jr.; Ferreira, A.M.; Frota, O.P.; Rigotti, M.A.; Barcelos, L.d.S.; Lopes de Sousa, A.F.; de Andrade, D.; Guerra, O.G.;
Furlan, M.C.R. Effectiveness of Surface Cleaning and Disinfection in a Brazilian Healthcare Facility. Open Nurs. J. 2018, 12, 36–44.
[CrossRef]
97. Anderson, D.J.; Moehring, R.W.; Weber, D.J.; Lewis, S.S.; Chen, L.F.; Schwab, J.C.; Becherer, P.; Blocker, M.; Triplett, P.F.; Knelson,
L.P.; et al. Effectiveness of targeted enhanced terminal room disinfection on hospital-wide acquisition and infection with
multidrug-resistant organisms and Clostridium difficile: A secondary analysis of a multicentre cluster randomised controlled trial
with crossover. Lancet Infect. Dis. 2018, 18, 845–853. [CrossRef]
98. Frota, O.P.; Ferreira, A.M.; Guerra, O.G.; Rigotti, M.A.; de Andrade, D.; Borges, N.M.A.; de Almeida, M.T. Efficiency of cleaning
and disinfection of surfaces: Correlation between assessment methods. Rev. Bras. Enferm. 2017, 70, 1176–1183. [CrossRef]
99. Blazejewski, C.; Wallet, F.; Rouzé, A.; Le Guern, R.; Ponthieux, S.; Salleron, J.; Nseir, S. Efficiency of hydrogen peroxide in
improving disinfection of ICU rooms. Crit. Care. 2015, 19, 30. [CrossRef]
100. Rutala, W.A.; Kanamori, H.; Gergen, M.F.; Knelson, L.P.; Sickbert-Bennett, E.E.; Chen, L.F.; Anderson, D.J.; Sexton, D.J.; Weber, D.J.
Enhanced disinfection leads to reduction of microbial contamination and a decrease in patient colonization and infection. Infect.
Control Hosp. Epidemiol. 2018, 39, 1118–1121. [CrossRef] [PubMed]
101. Mayfield, J.L.; Leet, T.; Miller, J.; Mundy, L.M. Environmental Control to Reduce Transmission of Clostridium difficile. Clin. Infect.
Dis. 2000, 31, 995–1000. [CrossRef] [PubMed]
102. Boyce, J.M.; Havill, N.L.; Guercia, K.A.; Schweon, S.J.; Moore, B.A. Evaluation of two organosilane products for sustained
antimicrobial activity on high-touch surfaces in patient rooms. Am. J. Infect. Control 2014, 42, 326–328. [CrossRef] [PubMed]
103. Bogusz, A.; Stewart, M.; Hunter, J.; Yip, B.; Reid, D.; Robertson, C.; Dancer, S.J. How quickly do hospital surfaces become
contaminated after detergent cleaning? Healthc. Infect. 2013, 18, 3–9. [CrossRef]
104. Casini, B.; Righi, A.; De Feo, N.; Totaro, M.; Giorgi, S.; Zezza, L.; Valentini, P.; Tagliaferri, E.; Costa, A.L.; Barnini, S.; et al.
Improving cleaning and disinfection of high-touch surfaces in intensive care during carbapenem-resistant Acinetobacter baumannii
endemo-epidemic situations. Int. J. Environ. Res. Public Health. 2018, 15, 2305. [CrossRef]
105. Fitton, K.; Barber, K.R.; Karamon, A.; Zuehlke, N.; Atwell, S.; Enright, S. Long-acting water-stable organosilane agent and its
sustained effect on reducing microbial load in an intensive care unit. Am. J. Infect. Control 2017, 45, 1214–1217. [CrossRef]
106. Vesley, D.; Klapes, N.A.; Benzow, K.; Le, C.T. Microbiological evaluation of wet and dry floor sanitization systems in hospital
patient rooms. Appl. Environ. Microbiol. 1987, 53, 1042–1045. [CrossRef]
107. Sigler, V.; Hensley, S. Persistence of mixed Staphylococci assemblages following disinfection of hospital room surfaces. J. Hosp.
Infect. 2013, 83, 253–256. [CrossRef]
108. Fattorini, M.; Buonocore, G.; Lenzi, D.; Burgassi, S.; Cardaci, R.M.R.; Biermann, K.P.; Cevenini, G.; Messina, G. Public Health
since the beginning: Neonatal incubators safety in a clinical setting. J. Infect. Public Health 2018, 11, 788–792. [CrossRef]
109. Hacek, D.M.; Ascp, M.T.; Ogle, A.M.; Fisher, A.; Ascp, M.T.; Robicsek, A. Significant impact of terminal room cleaning with
bleach on reducing nosocomial Clostridium difficile. Am. J. Infect. Control 2010, 38, 350–353. [CrossRef] [PubMed]
110. Butin, M.; Dumont, Y.; Monteix, A.; Raphard, A.; Roques, C.; Martins Simoes, P.; Picaud, J.C.; Laurent, F. Sources and reservoirs of
Staphylococcus capitis NRCS-A inside a NICU. Antimicrob. Resist. Infect. Control 2019, 8, 157. [CrossRef] [PubMed]
Int. J. Environ. Res. Public Health 2021, 18, 11100 18 of 22
111. Otter, J.A.; Mepham, S.; Athan, B.; Mack, D.; Smith, R.; Jacobs, M.; Hopkins, S. Terminal decontamination of the Royal Free
London’s high-level isolation unit after a case of Ebola virus disease using hydrogen peroxide vapor. Am. J. Infect. Control. 2016,
44, 233–235. [CrossRef] [PubMed]
112. Strassle, P.; Thom, K.A.; Johnsonm, J.K.; Leekha, S.; Lissauer, M.; Zhu, J.; Harris, A.D. The effect of terminal cleaning on
environmental contamination rates of multidrug-resistant Acinetobacter baumannii. Am. J. Infect. Control 2012, 40, 1005–1007.
[CrossRef]
113. Garvey, M.I.; Wilkinson, M.A.C.; Bradley, C.W.; Holden, K.L.; Holden, E. Wiping out MRSA: Effect of introducing a universal
disinfection wipe in a large UK teaching hospital. Antimicrob. Resist. Infect. Control 2018, 7, 155. [CrossRef]
114. Orenstein, R.; Aronhalt, K.C.; McManus, J.E., Jr.; Fedraw, L.A. A Targeted Strategy to Wipe Out Clostridium difficile. Infect. Control.
Hosp. Epidemiol. 2011, 32, 1137–1139.
115. Kaatz, G.W.; Gitlin, S.D.; Schaberg, D.R.; Wilson, K.H.; Kauffman, C.A.; Seo, S.M.; Fekety, R. Acquisition of Clostridium difficile
from the hospital environment. Am. J. Epidemiol. 1988, 127, 1289–1294. [CrossRef]
116. Youkee, D.; Brown, C.S.; Lilburn, P.; Shetty, N.; Brooks, T.; Simpson, A.; Bentley, N.; Lado, M.; Kamara, T.B.; Walker, N.F.; et al.
Assessment of Environmental Contamination and Environmental Decontamination Practices within an Ebola Holding Unit,
Freetown, Sierra Leone. PLoS ONE 2015, 10, e0145167. [CrossRef]
117. Mosci, D.; Marmo, G.W.; Sciolino, L.; Zaccaro, C.; Antonellini, R.; Accogli, L.; Lazzarotto, T.; Mongardi, M.; Landini, M.P.
Automatic environmental disinfection with hydrogen peroxide and silver ions versus manual environmental disinfection with
sodium hypochlorite: A multicentre randomized before-and-after trial. J. Hosp. Infect. 2017, 97, 175–179. [CrossRef]
118. Galván Contreras, R.-; Tapia, R.A.R.; Cervantes, E.S.; Aguilar, R.M.A.C. Comparative study on the effectiveness of 6% sodium
hypochlorite solution vs a bromine-chloro-dimethylhydantoin solution for disinfecting hospital environments. Perinatol. Reprod.
Hum. 2017, 30, 145–150.
119. Huang, Y.S.; Chen, Y.C.; Chen, M.L.; Cheng, A.; Hung, I.C.; Wang, J.T.; Sheng, W.H.; Chang, S.C. Comparing visual inspection,
aerobic colony counts, and adenosine triphosphate bioluminescence assay for evaluating surface cleanliness at a medical center.
Am. J. Infect. Control 2015, 43, 882–886. [CrossRef]
120. Patel, S.S.; Pevalin, D.J.; Prosser, R.; Couchman, A. Comparison of detergent-based cleaning, disinfectant-based cleaning, and
detergent-based cleaning after enhanced domestic staff training within a source isolation facility. Br. J. Infect. Control 2007, 8,
20–25. [CrossRef]
121. Wilcox, M.H.; Fawley, W.N.; Wigglesworth, N.; Parnell, P.; Verity, P.; Freeman, J. Comparison of the effect of detergent versus
hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J. Hosp. Infect. 2003, 54,
109–114. [CrossRef]
122. Barbut, F.; Menuet, D.; Verachten, M.; Girou, E. Comparison of the Efficacy of a Hydrogen Peroxide Dry-Mist Disinfection System
and Sodium Hypochlorite Solution for Eradication of Clostridium difficile Spores. Infect. Control Hosp. Epidemiol. 2009, 30, 507–514.
[CrossRef] [PubMed]
123. Zhang, A.; Nerandzic, M.M.; Kundrapu, S.; Donskey, C.J. Does Organic Material on Hospital Surfaces Reduce the Effectiveness
of Hypochlorite and UV Radiation for Disinfection of Clostridium difficile? Infect. Control Hosp. Epidemiol. 2013, 34, 1106–1108.
[CrossRef]
124. Anderson, D.J.; Chen, L.F.; Weber, D.J.; Moehring, R.W.; Lewis, S.S.; Triplett, P.F.; Blocker, M.; Becherer, P.; Schwab, J.C.; Knelson,
L.P.; et al. Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and
Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): A cluster-randomised, multicentre, crossover
study. Lancet 2017, 389, 805–814. [CrossRef]
125. Lerner, A.O.; Abu-Hanna, J.; Carmeli, Y.; Schechner, V. Environmental contamination by carbapenem-resistant Acinetobacter
baumannii: The effects of room type and cleaning methods. Infect. Control Hosp. Epidemiol. 2019, 41, 166–171. [CrossRef] [PubMed]
126. Jinadatha, C.; Quezada, R.; Huber, T.W.; Williams, J.B.; Zeber, J.E.; Copeland, L.A. Evaluation of a pulsed-xenon ultraviolet room
disinfection device for impact on contamination levels of methicillin-resistant Staphylococcus aureus. BMC Infect. Dis. 2014, 14, 187.
[CrossRef]
127. Casini, B.; Tuvo, B.; Cristina, M.L.; Spagnolo, A.M.; Totaro, M.; Baggiani, A.; Privitera, G.P. Evaluation of an Ultraviolet C (UVC)
Light-Emitting Device for Disinfection of High Touch Surfaces in Hospital Critical Areas. Int. J. Environ. Res. Public Health 2019,
16, 3572. [CrossRef]
128. Simon Garcia, M.J.; Gonzalez Sanchez, J.A.; Alcudia Perez, F.; Sanchez Sanchez, C.; Gomez Mayoral, B.; Merino Martinez, M.R.
Evaluation of the effect of a cleaning disinfection intervention on the rate of multiresistant microorganism infections in the
Intensive Care Unit. Enferm. Intensiva 2009, 20, 27–34. [PubMed]
129. Manian, F.A.; Griesnauer, S.; Bryant, A. Implementation of hospital-wide enhanced terminal cleaning of targeted patient rooms
and its impact on endemic Clostridium difficile infection rates. Am. J. Infect. Control 2013, 41, 537–541. [CrossRef]
130. Manian, F.A.; Griesenauer, S.; Senkel, D.; Setzer, J.M.; Doll, S.A.; Perry, A.M.; Wiechens, M. Isolation of Acinetobacter baumannii
Complex and Methicillin-Resistant Staphylococcus aureus from Hospital Rooms Following Terminal Cleaning and Disinfection:
Can We Do Better? Infect. Control Hosp. Epidemiol. 2011, 32, 667–672. [CrossRef] [PubMed]
131. Ghantoji, S.S.; Stibich, M.; Stachowiak, J.; Cantu, S.; Adachi, J.A.; Raad, I.I.; Chemaly, R.F. Non-inferiority of pulsed xenon UV
light versus bleach for reducing environmental Clostridium difficile contamination on high-touch surfaces in Clostridium difficile
infection isolation rooms. J. Med. Microbiol. 2015, 64, 191–194. [CrossRef]
Int. J. Environ. Res. Public Health 2021, 18, 11100 19 of 22
132. Coppin, J.D.; Villamaria, F.C.; Williams, M.D.; Copeland, L.A.; Zeber, J.E.; Jinadatha, C. Self-sanitizing copper-impregnated
surfaces for bioburden reduction in patient rooms. Am. J. Infect. Control 2017, 45, 692–694. [CrossRef] [PubMed]
133. Aucella, F.; Vigilante, M.; Valente, G.L.; Stallone, C. Systematic monitor disinfection is effective in limiting HCV spread in
hemodialysis. Blood Purif. 2000, 18, 110–114. [CrossRef]
134. Rathod, S.N.; Beauvais, K.; Sullivan, L.K.; Sudikoff, S.N.; Peaper, D.R.; Martinello, R.A. The effectiveness of a novel colorant
additive in the daily cleaning of patient rooms. Infect. Control Hosp. Epidemiol. 2019, 40, 721–723. [CrossRef]
135. Ho, Y.H.; Wang, L.S.; Jiang, H.L.; Chang, C.H.; Hsieh, C.J.; Chang, D.C.; Tu, H.Y.; Chiu, T.Y.; Chao, H.J.; Tseng, C.C. Use of
a sampling area-adjusted adenosine triphosphate bioluminescence assay based on digital image quantification to assess the
cleanliness of hospital surfaces. Int. J. Environ. Res. Public Health 2016, 13, 576. [CrossRef]
136. Hall, T.J.; Jeanes, A.; McKain, L.W.; Jepson, M.J.; Coen, P.G.; Hickok, S.S.; Gant, V.A. A UK district general hospital cleaning study:
A comparison of the performance of ultramicrofibre technology with or without addition of a novel copper-based biocide with
standard hypochlorite-based cleaning. J. Infect. Prev. 2011, 12, 232–236. [CrossRef]
137. Oztoprak, N.; Kizilates, F.; Percin, D. Comparison of steam technology and a two-step cleaning (water/detergent) and disinfecting
(1000 resp. 5000 ppm hypochlorite) method using microfiber cloth for environmental control of multidrug-resistant organisms in
an intensive care unit. GMS Hyg. Infect. Control. 2019, 14, Doc15.
138. Andersen, B.M.; Bånrud, H.; Bøe, E.; Bjordal, O.; Drangsholt, F. Comparison of UV C Light and Chemicals for Disinfection of
Surfaces in Hospital Isolation Units. Infect. Control Hosp. Epidemiol. 2006, 27, 729–734. [CrossRef] [PubMed]
139. Turner, A.G.; Hill, C.; Higgins, M.M.; Craddock, J.G.; Nc, C.H. Disinfection of Immersion Tanks (Hubbard) in a Hospital Burn
Unit. Arch Env. Health 1974, 28, 101–105. [CrossRef]
140. Chen, C.H.; Tu, C.C.; Kuo, H.Y.; Zeng, R.F.; Yu, C.S.; Lu, H.H.S.; Liou, M.L. Dynamic change of surface microbiota with different
environmental cleaning methods between two wards in a hospital. Appl. Microbiol. Biotechnol. 2017, 101, 771–781. [CrossRef]
[PubMed]
141. Best, E.L.; Parnell, P.; Thirkell, G.; Verity, P.; Copland, M.; Else, P.; Denton, M.; Hobson, R.P.; Wilcox, M.H. Effectiveness of deep
cleaning followed by hydrogen peroxide decontamination during high Clostridium difficile infection incidence. J. Hosp. Infect.
2014, 87, 25–33. [CrossRef]
142. Garvey, M.I.; Bradley, C.W.; Jumaa, P. Environmental decontamination following occupancy of a burns patient with multiple
carbapenemase-producing organisms. J. Hosp. Infect. 2016, 93, 136–140. [CrossRef] [PubMed]
143. Stewart, M.; Bogusz, A.; Hunter, J.; Devanny, I.; Yip, B.; Reid, D.; Robertson, C.; Dancer, S.J. Evaluating Use of Neutral Electrolyzed
Water for Cleaning Near-Patient Surfaces. Infect. Control Hosp. Epidemiol. 2014, 35, 1505–1510. [CrossRef]
144. Hosein, I.; Madeloso, R.; Nagaratnam, W.; Villamaria, F.; Stock, E.; Jinadatha, C. Evaluation of a pulsed xenon ultraviolet light
device for isolation room disinfection in a United Kingdom hospital. Am. J. Infect. Control. 2016, 44, e157–e161. [CrossRef]
145. Ojajärvi, J.; Mäkelä, P. Evaluation of Chlorine Compounds for Surface Disinfection by Laboratory and ln-use Testing. Scand. J.
Infect. Dis. 1976, 8, 267–270. [CrossRef]
146. Johnson, A.; Weston, L.; Grisewood, L.; Kyffin, M. Evaluation of the Ultra-VTM (ultraviolet) decontamination system as an adjunct
to cleaning in a district general hospital. J. Hosp. Infect. 2016, 94, 406–407. [CrossRef]
147. Frabetti, A.; Vandini, A.; Balboni, P.; Triolo, F.; Mazzacane, S. Experimental evaluation of the efficacy of sanitation procedures in
operating rooms. Am. J. Infect. Control 2009, 37, 658–664. [CrossRef]
148. Al-Hamad, A.; Maxwell, S. How clean is clean? Proposed methods for hospital cleaning assessment. J. Hosp. Infect. 2008, 70,
328–334. [CrossRef] [PubMed]
149. Goldenberg, S.D.; Patel, A.; Tucker, D.; French, G.L. Lack of enhanced effect of a chlorine dioxide-based cleaning regimen on
environmental contamination with Clostridium difficile spores. J. Hosp. Infect. 2012, 82, 64–67. [CrossRef] [PubMed]
150. Shelly, M.J.; Scanlon, T.G.; Ruddy, R.; Hannan, M.M.; Murray, J.G. Meticillin-resistant Staphylococcus aureus (MRSA) environmental
contamination in a radiology department. Clin. Radiol. 2011, 66, 861–864. [CrossRef] [PubMed]
151. Allen, O.; Jadkauskaite, L.; Shafi, N.T.; Jackson, A.; Athithan, V.; Chiu, Y.D.; IES, E.; Floto, R.A.; Haworth, C.S. Microbiological
evaluation of UV disinfection effectiveness in a specialist cystic fibrosis clinic. J. Cyst. Fibros. 2019, 18, e37–e39. [CrossRef]
[PubMed]
152. Casey, A.L.; Adams, D.; Karpanen, T.J.; Lambert, P.A.; Cookson, B.D.; Nightingale, P.; Miruszenko, L.; Shillam, R.; Christian, P.;
Elliott, T.S.J. Role of copper in reducing hospital environment contamination. J. Hosp. Infect. 2010, 74, 72–77. [CrossRef] [PubMed]
153. Gan, T.; Xu, H.; Wu, J.; Zhu, Y.; Wang, L.; Jin, H.; Wei, L.; Shen, L.; Ni, X.; Cao, J.; et al. Sequential enhanced cleaning eliminates
multidrug-resistant organisms in general intensive care unit of a traditional Chinese medicine hospital. J. Crit. Care 2017, 41,
216–221. [CrossRef] [PubMed]
154. Karpanen, T.J.; Casey, A.L.; Lambert, P.A.; Cookson, B.D.; Nightingale, P.; Miruszenko, L.; Elliott, T.S.J. The Antimicrobial Efficacy
of Copper Alloy Furnishing in the Clinical Environment: A Crossover Study. Infect. Control Hosp. Epidemiol. 2012, 33, 3–9.
[CrossRef]
155. Gable, T.S. Bactericidal effectiveness of floor cleaning methods in a hospital environment. Hospitals 1966, 40, 107–111. [PubMed]
156. Ogino, J.; Fujimori, I.; Goto, R.; Hisamastu, K.; Murakami, Y.; Yamada, T.; Kikushima, K. Efficacy of pyoktanin and DF-100 for
prevention of nosocomial MRSA infection. Pract. Otol. Suppl. 1995, 79, 104–109.
157. Smith, T.L.; Iwen, P.C.; Olson, S.B.; Rupp, M.E. Environmental contamination with vancomycin-resistant Enterococci in an
outpatient setting. Infect. Control Hosp. Epidemiol. 1998, 19, 515–518. [CrossRef]
Int. J. Environ. Res. Public Health 2021, 18, 11100 20 of 22
158. Meinke, R.; Meyer, B.; Frei, R.; Passweg, J.; Widmer, A.F. Equal Efficacy of Glucoprotamin and an Aldehyde Product for
Environmental Disinfection in a Hematologic Transplant Unit: A Prospective Crossover Trial. Infect. Control Hosp. Epidemiol. 2012,
33, 1077–1080. [CrossRef]
159. Stibich, M.; Stachowiak, J.; Tanner, B.; Berkheiser, M.; Moore, L.; Raad, I.; Chemaly, R.F. Evaluation of a Pulsed-Xenon Ultraviolet
Room Disinfection Device for Impact on Hospital Operations and Microbial Reduction. Infect. Control Hosp. Epidemiol. 2011, 32,
286–288. [CrossRef]
160. Danforth, D.; Nicolle, L.E.; Hume, K.; Alfieri, N.; Sims, H. Nosocomial infections on nursing units with floors cleaned with a
disinfectant compared with detergent. J. Hosp. Infect. 1987, 10, 229–235. [CrossRef]
161. Tekin, A.; Dal, T.; Selçuk, C.T.; Deveci, Ö.; Tekin, R.; Mete, M.; Dayan, S.; Hoşoǧlu, S. Orthophenylphenol in healthcare
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